Neurocrine Biosciences (NBIX) News Today → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free nbix Stock Alerts $138.89 +2.90 (+2.13%) (As of 04/29/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRussell Investments Group Ltd. Sells 8,564 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)marketbeat.com - April 29 at 7:24 AMShort Interest in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Drops By 16.9%americanbankingnews.com - April 28 at 3:14 AMPromising Outlook for Neurocrine’s NBI-‘845 in MDD Market Based on Strong Phase 2 Results and Competitive Positioningmarkets.businessinsider.com - April 27 at 4:58 AMBuy Rating Affirmed for Neurocrine on Promising Phase 2 SAVITRI Study Resultsmarkets.businessinsider.com - April 26 at 1:56 PMMaintaining Hold on Neurocrine Amid Promising Yet Uncertain Clinical Developmentsmarkets.businessinsider.com - April 26 at 1:56 PMNew York State Common Retirement Fund Sells 29,456 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)marketbeat.com - April 26 at 7:44 AMAnalysts Set Expectations for Neurocrine Biosciences, Inc.'s Q1 2025 Earnings (NASDAQ:NBIX)americanbankingnews.com - April 26 at 3:50 AMWells Fargo Upgrades Neurocrine Biosciences (NBIX)msn.com - April 25 at 8:21 PMBrokers Set Expectations for Neurocrine Biosciences, Inc.'s Q1 2025 Earnings (NASDAQ:NBIX)marketbeat.com - April 25 at 8:31 AMNeurocrine Biosciences (NASDAQ:NBIX) Upgraded by Wells Fargo & Company to Overweightamericanbankingnews.com - April 25 at 7:02 AMNeurocrine Biosciences (NASDAQ:NBIX) Shares Gap Up to $133.66americanbankingnews.com - April 25 at 6:17 AMNeurocrine launches CAH community website ahead of FDA filingmsn.com - April 25 at 12:18 AMWall Street Analysts Are Neutral on Top Healthcare Picksmarkets.businessinsider.com - April 24 at 2:15 PMNeurocrine Biosciences upgraded at Wells Fargo on pipelinemsn.com - April 24 at 2:15 PMNeurocrine Biosciences Launches WHAT THE C@H?! Educational Initiative to Support Congenital Adrenal Hyperplasia Communityfinance.yahoo.com - April 24 at 9:14 AMNeurocrine Biosciences (NASDAQ:NBIX) Earns Buy Rating from HC Wainwrightmarketbeat.com - April 24 at 8:35 AM3 Red-Hot Biotech Rockets Blasting Off in 2024investorplace.com - April 24 at 8:00 AMJennison Associates LLC Grows Stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)marketbeat.com - April 24 at 7:19 AMNeurocrine Biosciences (NASDAQ:NBIX) Lifted to Overweight at Wells Fargo & Companymarketbeat.com - April 24 at 7:08 AMNeurocrine Biosciences (NASDAQ:NBIX) Given Hold Rating at Needham & Company LLCamericanbankingnews.com - April 24 at 4:48 AMNeurocrine Biosciences (NBIX) Scheduled to Post Quarterly Earnings on Wednesdayamericanbankingnews.com - April 24 at 4:12 AMDoes Neurocrine, The No. 1 Biotech Stock, Have The Next Ketamine On Its Hands?finance.yahoo.com - April 23 at 6:12 PMNo. 1 Biotech Stock Neurocrine Launches Higher On Depression Treatment Winfinance.yahoo.com - April 23 at 1:11 PMNeurocrine Biosciences (NASDAQ:NBIX) Receives Hold Rating from Needham & Company LLCmarketbeat.com - April 23 at 8:43 AMNeurocrine's Phase 2 SAVITRI Study Meets Primary Endpoint For NBI-1065845 In Adults With MDDmarkets.businessinsider.com - April 23 at 8:09 AM10 Best Performing Biotech ETFs in 2024finance.yahoo.com - April 22 at 12:07 PMNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Hussman Strategic Advisors Inc.marketbeat.com - April 22 at 9:17 AM14,857 Shares in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Purchased by Strs Ohiomarketbeat.com - April 21 at 5:25 AMNeurocrine Biosciences, Inc. to Post FY2025 Earnings of $6.58 Per Share, William Blair Forecasts (NASDAQ:NBIX)americanbankingnews.com - April 20 at 3:22 AMContrasting Taysha Gene Therapies (NASDAQ:TSHA) and Neurocrine Biosciences (NASDAQ:NBIX)americanbankingnews.com - April 20 at 1:40 AMWilliam Blair Weighs in on Neurocrine Biosciences, Inc.'s FY2025 Earnings (NASDAQ:NBIX)marketbeat.com - April 19 at 9:18 AMRoman Butler Fullerton & Co. Buys New Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)marketbeat.com - April 18 at 10:41 AMInsider Selling: Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Insider Sells 19,818 Shares of Stockinsidertrades.com - April 18 at 6:04 AMSentia and Neurocrine extend collaboration on peptide therapeuticsinvesting.com - April 18 at 1:42 AMWedbush Reaffirms Outperform Rating for Neurocrine Biosciences (NASDAQ:NBIX)marketbeat.com - April 17 at 3:51 PMValidea Detailed Fundamental Analysis - NBIXnasdaq.com - April 17 at 9:25 AM12,617 Shares in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Bought by HealthInvest Partners ABmarketbeat.com - April 16 at 6:50 PMThe 5 Stocks Most Sold By Insiders This Year (NBIX)insidertrades.com - April 16 at 10:45 AMNxera Pharma Notes Successful Development Progress of Partnered Schizophrenia Candidate NBI-1117568globenewswire.com - April 16 at 2:30 AMLouisiana State Employees Retirement System Invests $3.64 Million in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)marketbeat.com - April 15 at 7:33 AMLeerink Partnrs Comments on Neurocrine Biosciences, Inc.'s Q1 2024 Earnings (NASDAQ:NBIX)marketbeat.com - April 11 at 7:26 AMNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Bought by Allspring Global Investments Holdings LLCmarketbeat.com - April 11 at 6:58 AMNeurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2024 Financial Resultsprnewswire.com - April 10 at 4:01 PMNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Impax Asset Management Group plcmarketbeat.com - April 10 at 10:46 AMCantor Fitzgerald Reaffirms Overweight Rating for Neurocrine Biosciences (NASDAQ:NBIX)marketbeat.com - April 10 at 10:25 AMTobam Lowers Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)marketbeat.com - April 9 at 11:47 AMNeurocrine begins phase 2 trial for depression druguk.investing.com - April 5 at 4:00 PMNeurocrine Biosciences executive sells shares worth over $37kinvesting.com - April 5 at 4:00 PMChina Universal Asset Management Co. Ltd. Buys 8,860 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)marketbeat.com - April 4 at 6:54 PMWells Fargo Reaffirms Their Hold Rating on Neurocrine (NBIX)markets.businessinsider.com - April 3 at 2:38 PM Get Neurocrine Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NBIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Have You Seen Elon’s New A.I. Device? (Picture Inside) (Ad)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast... This strange new device to protect us against that A.I. threat... NBIX Media Mentions By Week NBIX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NBIX News Sentiment▼0.620.34▲Average Medical News Sentiment NBIX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NBIX Articles This Week▼338▲NBIX Articles Average Week Get Neurocrine Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NBIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Repligen News Today Exelixis News Today Halozyme Therapeutics News Today Denali Therapeutics News Today Adaptive Biotechnologies News Today Biogen News Today Qiagen News Today Vaxcyte News Today Revolution Medicines News Today BioNTech News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NBIX) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsNvidia CEO Says It Will Be “the Next Revolution” Beyond AIBanyan Hill PublishingCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 Media4 coins to be the “Next Bitcoin”True Market InsidersForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurocrine Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
